2024, November 26
Share this articleNU School of Medicine and Vi-ORTIS information and analytics company signed a memorandum of cooperation aimed at advancing scientific research, educational programs, and innovative projects.
Vi-ORTIS is Kazakhstan’s first domestic analytics company, delivering insights into the pharmaceutical market and its trends for over 20 years. The company supports scientific initiatives in the pharmaceutical sector, integrates its analytics into educational programs and case studies, and equips students to address real-world market challenges.
According to the memorandum, the key areas of cooperation will be:
“This memorandum holds significant strategic importance as it combines academic expertise and innovation with practical analytical and IT solutions. The range of analytics that our company will provide under this partnership will greatly support the development of research and educational programs, contributing to the preparation of skilled professionals and boosting our country’s competitiveness,” highlighted Nailya Cherednichenko, General Director of Vi-ORTIS.
“This partnership exemplifies genuine synergy, where the expertise and resources of both sides complement each other perfectly, reflecting our shared commitment to advancing education, research, and innovation for the benefit of all,” added NU Vice President and Dean of the NU School of Medicine Massimo Pignatelli.
The collaboration between NU and Vi-ORTIS is expected to be a catalyst for transformation in Kazakhstan’s educational and scientific ecosystems, strengthening the foundation for an innovative future.
